drasha.qa

Obesity is a disease—not a choice.
At ECO and EASO, the future of obesity management is moving fast, with new medications reshaping care for a condition affecting over 1 billion people worldwide.
But we must not overlook the link between obesity, sleep disorders, and obstructive sleep apnea, especially in children. Early recognition and comprehensive treatment can change lifelong health outcomes.

A new chapter in obesity medicine—oral GLP-1 therapy is redefining accessibility and adherence.
No injections. Simplified care. Meaningful outcomes.
This is where metabolic treatment is heading.”